Gatek J, Vrana D, Melichar B, Vazan P, Kotocova K, Kotoc J, Dudesek B, Hnatek L, Duben J
Department of Surgery, Atlas Hospital, Tomas Bata University in Zlin, Zlin, Czech Republic.
J BUON. 2012 Jul-Sep;17(3):452-6.
While positive resection margin (RM) in women undergoing breast-conserving surgery (BCS) represents a clear indication for re-resection, there is no unequivocal recommendation regarding the extent of the clear RM. The aim of this study was to define the optimal extent of the RM and the risk factors for close or positive RM.
Patients scheduled for BCS had diagnosis confirmed before BCS (lumpectomy and quadrantectomy) by core biopsy. Sentinel lymph node biopsy followed BCS, and in case of positive findings axillary lymph node dissection followed. According to RM patients were categorized into 4 groups: 1) Patients with positive RM; 2) Clear RM < 2 mm; 3) Clear RM of 2-5 mm; and 4) RM > 5 mm. In the first 3 groups where re-resection was indicated, the presence of tumor cells in the re-resection specimen was determined. All patients were followed for local recurrence.
330 patients undergoing BCS were studied. Median follow up was 39.6 months (range 12-70). Lumpectomy was performed in 111 cases and quadrantectomy in 219. In 19 cases the final procedure was mastectomy due to the impossibility to achieve negative RM. In 78 cases re-resection followed the primary procedure due to close or positive RM. Clear RM was < 2 mm in 12 cases (15%), 2-5 mm in 56 (72%) and positive margin in 10 (13%). Positive re-resection specimen was detected in 31 cases (39.7%) (in 10 cases with positive RM after primary procedure, in 3 with negative margin < 2 mm and in 18 with 2-5 mm margin). The re-resection rate according to the location of the primary tumor was 77% (n=60) in the upper outer quadrant, 8% (n=6) in the lower outer quadrant, 6% (n=5) in the upper inner quadrant, 4% (n=3) in the lower inner quadrant, and 5% (n=4) in centrally located tumors. Multicentric/ multifocal tumor was diagnosed in 16 cases from which re-resection was indicated in 12 cases (75%). The number of re-resection according to tumor size was as follows: Tis 8 cases (30.7%), T1a none, T1b 14 (20.2%), T1c 34 (22.5%), T2 22 (28%). Re-resection was performed in 8 cases (31%) of ductal carcinoma in situ (DCIS), in 53 (22%) of ductal carcinoma, in 10 (37%) of lobular carcinoma, and in 7 (15%) of other histology. Five cases with local relapse were detected during follow up.
The generally recommended clear RM of 1-5 mm is not sufficient because of the high number of positive specimens in the case of clear RM of 2-5 mm. The risk factors for close or positive RM are multicentric tumors and upper outer location of the primary tumor. Longer follow up will be needed to analyze local relapse rate according to RM status.
对于接受保乳手术(BCS)的女性,切缘阳性(RM)明确提示需再次手术切除,但对于切缘阴性的安全范围尚无明确建议。本研究旨在确定切缘阴性的最佳范围以及切缘接近或阳性的危险因素。
计划接受保乳手术的患者在手术(肿块切除术和象限切除术)前通过粗针活检确诊。保乳手术后进行前哨淋巴结活检,若结果为阳性则行腋窝淋巴结清扫。根据切缘情况将患者分为4组:1)切缘阳性患者;2)切缘阴性<2mm;3)切缘阴性2 - 5mm;4)切缘阴性>5mm。在前3组提示需再次手术切除的患者中,确定再次切除标本中是否存在肿瘤细胞。所有患者均进行局部复发随访。
对330例行保乳手术的患者进行了研究。中位随访时间为39.6个月(范围12 - 70个月)。111例行肿块切除术,219例行象限切除术。19例因无法获得阴性切缘最终行乳房切除术。78例因切缘接近或阳性在初次手术后进行了再次手术切除。切缘阴性<2mm的有12例(15%),2 - 5mm的有56例(72%),切缘阳性的有10例(13%)。31例(39.7%)再次切除标本结果为阳性(初次手术后切缘阳性的10例,切缘阴性<2mm的3例,切缘阴性2 - 5mm的18例)。根据原发肿瘤位置,再次手术切除率如下:外上象限为77%(n = 60),外下象限为8%(n = 6),内上象限为6%(n = 5),内下象限为4%(n = 3),中央型肿瘤为5%(n = 4)。16例诊断为多中心/多灶性肿瘤,其中12例(75%)需再次手术切除。根据肿瘤大小,再次手术切除情况如下:Tis为8例(30.7%),T1a无,T1b为14例(20.2%),T1c为34例(22.5%),T2为22例(28%)。导管原位癌(DCIS)8例(31%)、导管癌53例(22%)、小叶癌10例(37%)、其他组织学类型7例(15%)进行了再次手术切除。随访期间发现5例局部复发。
一般推荐的1 - 5mm切缘阴性范围并不足够,因为切缘阴性2 - 5mm时阳性标本数量较多。切缘接近或阳性的危险因素是多中心肿瘤和原发肿瘤位于外上象限。需要更长时间的随访以分析根据切缘情况的局部复发率。